About Inferior Vena Cava (IVC) Filters
The IVCF is a type of vascular filter that is inserted into the inferior vena cava to prevent blood clots from moving from the veins in the legs and pelvis to the lung, which can lead to life-threatening pulmonary embolism (PE).
Technavio’s analysts forecast the global inferior vena cava (IVC) filters market to grow at a CAGR of 11.24% during the period 2018-2022.
Covered in this report
The report covers the present scenario and the growth prospects of the global inferior vena cava (IVC) filters market for 2018-2022. To calculate the market size, the report presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources.
The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA
Technavio's report, Global Inferior Vena Cava (IVC) Filters Market 2018-2022, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
• Argon Medical Devices
• B. Braun Melsungen
• Boston Scientific
• C. R. Bard
• Cook Medical
Market driver
• Increasing incidence of venous thromboembolism (VTE)
• For a full, detailed list, view our report
Market challenge
• High cost of the IVCF devices and procedures
• For a full, detailed list, view our report
Market trend
• Technological advances
• For a full, detailed list, view our report
Key questions answered in this report
• What will the market size be in 2022 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
Table of Contents
PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
PART 03: RESEARCH METHODOLOGY
PART 04: MARKET LANDSCAPE
• Market ecosystem
• Market characteristics
• Market segmentation analysis
PART 05: MARKET SIZING
• Market definition
• Market sizing 2017
• Market size and forecast 2017-2022
PART 06: FIVE FORCES ANALYSIS
• Bargaining power of buyers
• Bargaining power of suppliers
• Threat of new entrants
• Threat of substitutes
• Threat of rivalry
• Market condition
PART 07: MARKET SEGMENTATION BY PRODUCT
• Overview
• Comparison by product
• Optional IVCFs and temporary IVCFs
• Permanent IVCFs
• Market opportunity by product
PART 08: CUSTOMER LANDSCAPE
PART 09: REGIONAL LANDSCAPE
• Geographical segmentation
• Regional comparison
• IVCFs market in Americas
• IVCFs market in EMEA
• IVCFs market in APAC
• Key leading countries
• Market opportunity
PART 10: MARKET SEGMENTATION BY END-USER
PART 11: DECISION FRAMEWORK
PART 12: DRIVERS AND CHALLENGES
• Market drivers
• Market challenges
PART 13: MARKET TRENDS
• Technological advances
• Strategic M&A and collaborations
• Expanding indications
PART 14: VENDOR LANDSCAPE
• Overview
• Landscape disruption
• Competitive scenario
PART 15: VENDOR ANALYSIS
• Vendors covered
• Vendor classification
• Market positioning of vendors
• Argon Medical Devices
• B. Braun Melsungen
• Boston Scientific
• Cook Medical
• C. R. Bard
• Cardinal Health
• Other prominent vendors
PART 16: APPENDIX
• List of abbreviations
List of Exhibits
Exhibit 01: Global peripheral vascular devices market
Exhibit 02: Global peripheral vascular devices market
Exhibit 03: Market characteristics
Exhibit 04: Market segments
Exhibit 05: Market definition - Inclusions and exclusions checklist
Exhibit 06: Market size 2017
Exhibit 07: Validation techniques employed for market sizing 2017
Exhibit 08: Global IVCFs market 2017-2022 ($ millions)
Exhibit 09: Global IVCFs market: Year-over-year growth 2018-2022 (%)
Exhibit 10: Five forces analysis 2017
Exhibit 11: Five forces analysis 2022
Exhibit 12: Bargaining power of buyers
Exhibit 13: Bargaining power of suppliers
Exhibit 14: Threat of new entrants
Exhibit 15: Threat of substitutes
Exhibit 16: Threat of rivalry
Exhibit 17: Market condition - Five forces 2017
Exhibit 18: Global IVCFs market: Segmentation by product 2017-2022 (%)
Exhibit 19: Comparison by product
Exhibit 20: Optional IVCFs and temporary IVCFs available in market
Exhibit 21: Global optional IVCFs and temporary IVCFs market 2017-2022 ($ millions)
Exhibit 22: Global optional IVCFs and temporary IVCFs market: Year-over-year growth 2018-2022 (%)
Exhibit 23: Permanent IVCFs available in market
Exhibit 24: Global permanent IVCFs market 2017-2022 ($ millions)
Exhibit 25: Global permanent IVCFs market: Year-over-year growth 2018-2022 (%)
Exhibit 26: Market opportunity by product
Exhibit 27: Customer landscape
Exhibit 28: Global IVCFs market: Segmentation by geography 2017-2022 (%)
Exhibit 29: Regional comparison
Exhibit 30: IVCFs market in Americas 2017-2022 ($ millions)
Exhibit 31: IVCFs market in Americas: Year-over-year growth 2018-2022 (%)
Exhibit 32: Top 3 countries in Americas
Exhibit 33: IVCFs market in EMEA 2017-2022 ($ millions)
Exhibit 34: IVCFs market in EMEA: Year-over-year growth 2018-2022 (%)
Exhibit 35: Top 3 countries in EMEA
Exhibit 36: IVCFs market in APAC 2017-2022 ($ millions)
Exhibit 37: IVCFs market in APAC: Year-over-year growth 2018-2022 (%)
Exhibit 38: Top 3 countries in APAC
Exhibit 39: Key leading countries
Exhibit 40: Market opportunity
Exhibit 41: Global IVCFs market share by end user 2017 (%)
Exhibit 42: Vendor landscape
Exhibit 43: Landscape disruption
Exhibit 44: Competitive structure analysis of global IVCFs market 2017
Exhibit 45: Vendors covered
Exhibit 46: Vendor classification
Exhibit 47: Market positioning of vendors
Exhibit 48: Argon Medical Devices: Overview
Exhibit 49: Argon Medical Devices: Business segments
Exhibit 50: Argon Medical Devices: Organizational developments
Exhibit 51: Argon Medical Devices: Geographic focus
Exhibit 52: Argon Medical Devices: Segment focus
Exhibit 53: Argon Medical Devices: Key offerings
Exhibit 54: Argon Medical Devices: Key customers
Exhibit 55: B. Braun Melsungen: Overview
Exhibit 56: B. Braun Melsungen: Business segments
Exhibit 57: B. Braun Melsungen: Organizational developments
Exhibit 58: B. Braun Melsungen: Geographic focus
Exhibit 59: B. Braun Melsungen: Segment focus
Exhibit 60: B. Braun Melsungen: Key offerings
Exhibit 61: B. Braun Melsungen: Key customers
Exhibit 62: Vendor overview
Exhibit 63: Boston Scientific – Business segments
Exhibit 64: Boston Scientific – Organizational developments
Exhibit 65: Boston Scientific – Geographic focus
Exhibit 66: Boston Scientific – Segment focus
Exhibit 67: Boston Scientific – Key offerings
Exhibit 68: Boston Scientific– Key customers
Exhibit 69: Cook Medical: Overview
Exhibit 70: Cook Medical: Business segments
Exhibit 71: Cook Medical: Organizational developments
Exhibit 72: Cook Medical: Geographic focus
Exhibit 73: Cook Medical: Segment focus
Exhibit 74: Cook Medical: Key offerings
Exhibit 75: Cook Medical: Key customers
Exhibit 76: C. R. Bard: Overview
Exhibit 77: C. R. Bard: Business segments
Exhibit 78: C. R. Bard: Organizational developments
Exhibit 79: C. R. Bard: Geographic focus
Exhibit 80: C. R. Bard: Segment focus
Exhibit 81: C. R. Bard: Key offerings
Exhibit 82: C. R. Bard: Key customers
Exhibit 83: Cardinal Health: Overview
Exhibit 84: Cardinal Health: Business segments
Exhibit 85: Cardinal Health: Organizational developments
Exhibit 86: Cardinal Health: Geographic focus
Exhibit 87: Cardinal Health: Segment focus
Exhibit 88: Cardinal Health: Key offerings
Exhibit 89: Cardinal Health: Key customers
